Hospira Inc. recalls HEXTEND 6% Hetastarch in Lactated Electrolyte Injection, 500 mL, Rx only , MANUFACTURED AND DISTRIBUTED BY HOSPIRA, INC.
Recalled March 13, 2013 · FDA recall D-184-2013 · Hospira
Hazard
Lack of Assurance of Sterility: There is the potential for the solution to leak from the seal of the fill tube to the bag. · FDA Class II
Units
11,412 bags
Sold at
Nationwide
Description
Lack of Assurance of Sterility: There is the potential for the solution to leak from the seal of the fill tube to the bag.
Product
HEXTEND 6% Hetastarch in Lactated Electrolyte Injection, 500 mL, Rx only , MANUFACTURED AND DISTRIBUTED BY HOSPIRA, INC., LAKE FOREST, IL 60045, NDC 0409-1555-54
Manufacturer(s)
Hospira Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →